WHO Launches Global Monitoring Network for Dangerous Infectious Disease Outbreaks

Global collaboration in decoding genetics of infectious diseases like HIV and COVID-19 is crucial in managing outbreaks, say health experts.

An international group of health experts have launched a global network designed to monitor for infectious disease threats by sharing genetic disease data from around the world, which can be used to develop new vaccines and treatments, reducing the risks associated with widespread outbreaks.

The Worldwide Health Organization (WHO) issued a press release on May 20, announcing the International Pathogen Surveillance Network (IPSN), which will use global health experts to  identify, monitor, and respond to disease threats through genetic research.

IPSN was formed after international efforts on COVID-19 genomic sequencing led to a breakthrough vaccine for the virus. Genetic sequencing analyzes the genetic codes of viruses, bacteria, and other infection causing organisms known as pathogens.

The global collaboration was crucial in developing the COVID-19 vaccine, which helped stop the pandemic’s spread. Before the vaccine’s development, nursing home residents were among the most vulnerable to COVID-19 infection, and most U.S. nursing homes had multiple COVID-19 outbreaks.

Global Monitoring Critical in Preventing Future Pandemics

According to WHO, the IPSN will be made up of international health experts from governments, philanthropic organizations, civil services, academia, and private corporations. IPSN members will use a global online platform to collect and analyze disease DNA samples, share that research data, and collaborate on public health decisions.

The group will focus on genetic sequencing and data analytics which it hopes will help the world prepare for, and respond to, existing and emerging disease outbreak threats. The ISPN also hopes its research will lead to the development of infection treatments and vaccines.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

WHO stresses that global monitoring of infectious diseases is instrumental in managing many worldwide health threats. Pathogens including tuberculosis, HIV, influenza, and bacteria linked to food poisoning outbreaks are all under active international health surveillance.

IPSN’s launch event at the 2023 World Health Assembly in Geneva emphasized the importance of global, data driven infectious disease monitoring, especially since many developing countries lack robust infection surveillance systems from post-COVID 19 pandemic budget cuts.

“Global collaboration in pathogen genomic surveillance has been critical as the world fights COVID-19 together,” said Dr. Rajiv J. Shah, President of The Rockefeller Foundation, during the launch event. “IPSN builds upon this experience by creating a strong platform for partners across sectors and borders to share knowledge, tools, and practices to ensure that pandemic prevention and response is innovative and robust in the future.”

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted yesterday)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 3 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.